BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hashempour T, Dehghani B, Mousavi Z, Yahaghi M, Hasanshahi Z, Moayedi J, Akbari T, Davarpanah MA. Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients. Int J Pept Res Ther 2020;26:1699-710. [DOI: 10.1007/s10989-019-09957-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ghasabi F, Hashempour A, Khodadad N, Bemani S, Keshani P, Shekiba MJ, Hasanshahi Z. First report of computational protein–ligand docking to evaluate susceptibility to HIV integrase inhibitors in HIV-infected Iranian patients. Biochemistry and Biophysics Reports 2022;30:101254. [DOI: 10.1016/j.bbrep.2022.101254] [Reference Citation Analysis]
2 Hashempour T, Dehghani B, Musavi Z, Moayedi J, Hasanshahi Z, Sarvari J, Hosseini SY, Hosseini E, Moeini M, Merat S. Impact of IL28 Genotypes and Modeling the Interactions of HCV Core Protein on Treatment of Hepatitis C. Interdiscip Sci 2020;12:424-37. [PMID: 32656614 DOI: 10.1007/s12539-020-00382-8] [Reference Citation Analysis]
3 Dehghani B, Hasanshahi Z, Hashempour T. HIV Capsid and Protease, New Targets of Melittin. Int J Pept Res Ther 2020;26:2057-65. [DOI: 10.1007/s10989-019-10002-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]